🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Turn Therapeutics Inc. (TTRX)
NASDAQ: TTRX · Real-Time Price · USD
8.89
+0.34 (3.98%)
Nov 18, 2026, 4:00 PM EST - Market closed

Turn Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Cost of Revenue
2.250.5---
Gross Profit
-2.25-0.5---
Selling, General & Admin
5.85.591.552.34.21
Research & Development
1.220.270.250.01-
Operating Expenses
7.025.861.82.314.21
Operating Income
-9.27-6.36-1.8-2.31-4.21
Interest Expense
-0.7----0.09
Interest & Investment Income
0.240.030.030.020.01
Other Non Operating Income (Expenses)
-3.033.13---
Pretax Income
-12.77-3.19-1.77-2.29-4.29
Income Tax Expense
----0
Net Income
-12.77-3.19-1.77-2.29-4.29
Net Income to Common
-12.77-3.19-1.77-2.29-4.29
Net Income Growth
-----
Shares Outstanding (Basic)
29282726-
Shares Outstanding (Diluted)
29282726-
Shares Change
7.74%4.03%0.56%--
EPS (Basic)
-0.43-0.12-0.07-0.09-
EPS (Diluted)
-0.43-0.12-0.07-0.09-
EPS Growth
-----

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
EBITDA
-9.22-6.3-1.75-2.26-4.16
D&A For EBITDA
0.060.050.050.040.05
EBIT
-9.27-6.36-1.8-2.31-4.21
SEC Filings: 10-K · 10-Q